Lamostad 150 mg/40 mg Tablet
By Lamostad
Rx
10 Tablet in a Strip

Composition
Lamivudine(150mg) + Stavudine(40mg)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
September, 2025

liver
Lamostad 150 mg/40 mg Tablet is considered safe for use in individuals with liver disease. The available information indicates that adjusting the dose of Lamostad 150 mg/40 mg Tablet may not be necessary for these patients. However, it is essential to consult your doctor regarding its usage. If you experience any symptoms of jaundice while on Lamostad 150 mg/40 mg Tablet, it is important to inform your doctor promptly, as you may need to discontinue the medication.

kidney
Caution should be exercised when using Lamostad 150 mg/40 mg Tablet in patients with kidney disease. Dose adjustment might be necessary. Consult with your doctor for proper guidance.

alcohol
Caution is advised when drinking alcohol while taking Lamostad 150 mg/40 mg Tablet. Consult your doctor for guidance.

driving
When using Lamostad 150 mg/40 mg Tablet, be cautious while driving as it may reduce alertness, impact vision, and cause drowsiness or dizziness. Refrain from driving if experiencing these symptoms.

pregnancy
During pregnancy, caution is advised when using Lamostad 150 mg/40 mg Tablet, as it may not be safe. Animal studies have indicated potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing this medication to you. Please consult your doctor.

breastfeeding
Lamostad 150 mg/40 mg Tablet is considered safe during breastfeeding. Data indicates minimal risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹109.9
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025